JG
TXG icon

Jefferies Group’s 10x Genomics TXG Stock Holding History

Jefferies Group’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10,000
Closed -$1.46M – 2001
2021
Q3 		$1.46M Buy
+10,000
New +$1.72M 0.01% 860
2020
Q3 		– Sell
-10,000
Closed -$893 – 1550
2020
Q2 		$893 Hold
10,000
– – 0.01% 791
2020
Q1 		$623K Buy
+10,000
New +$780K 0.01% 1239

Other funds holding TXG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Jefferies Group's TXG Position: Q3 2020 in Review

Jefferies Group sold out of 10x Genomics (TXG) in Q3 2020, closing a stake of 667 shares — an estimated $60 sold.

Jefferies Group first reported a position in TXG in Q2 2020 and held it in 1 quarter. The position peaked at $60 in Q2 2020. 218 funds tracked by Wall St. Rank hold TXG as of Q3 2020.

  • Jefferies Group reported no remaining 10x Genomics position as of Q3 2020 after selling out during the quarter.
  • Jefferies Group sold 667 10x Genomics shares in Q3 2020, an estimated $60.
  • Jefferies Group first reported a position in 10x Genomics in Q2 2020 and held it in 1 quarter.
  • Jefferies Group's 10x Genomics position peaked at $60 in Q2 2020.
  • 218 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2020.

Based on Jefferies Group's 13F filing for Q3 2020, filed 13 Nov 2020.